A systematic review of remuneration systems for clinical pharmacy care services

Canadian Pharmacists Journal

Volumn 141, Issue 2, 2008, Pages 102-112

  Chan, Phil ^a,c   Grindrod, Kelly ^b   Bougher, David ^a   Pasutto, Franco M ^c   Wilgosh, Chuck ^a   Eberhart, Greg ^d   Tsuyuki, Ross ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Alberta College of Pharmacists   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

ACCREDITATION; ARTICLE; CLINICAL PHARMACY; CLINICAL PRACTICE; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HOSPITAL ORGANIZATION; HUMAN; LAW; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PATIENT EDUCATION; SYSTEMATIC REVIEW;

EID: 41949138672     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X(2008)141[102:ASRORS]2.0.CO;2     Document Type: Article

References (55)

1. Jones EJ, MacKinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother 2005;39:1527-33.
2. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. Arch Intern Med 2002;162:1149-55.
3. Tsuyuki RT, Olson KL, Dubyk AM, et al. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Am J Med 2004;116:130-3.
4. Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990-2002. Australia: University of South Australia; 2002. p. 1-202. Available: www.beta. guild.org.au/uploadedfiles/Research_and_Development_ Grants_ Program/Projects/2002-507_fr.pdf (accessed April 23, 2007).
5. Centers for Medicare and Medicaid Services. Covered medical and other health services. In: Medicare Benefit Policy Manual; 2006;93-9. Available: www.cms.hhs.gov/manuals/ Downloads/bp102c15.pdf (accessed September 12, 2007).
6. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.
7. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
8. Impact of pharmaceutical care delivered in the community pharmacy setting: results of a two year demonstration projects. Iowa Pharmacist 2000;55:18-24.
9. Farris KB, Kumbera P, Halterman T, Fang G. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services. J Manag Care Pharm 2002;8:383-93.
10. Fudge RP, Latiolais CJ. Blue Cross pays for clinical pharmacist services in training hemophiliacs for home care self-therapy. Pharm Times 1976;42:36-41.
11. Maddox RR, Vanderveen TW, Jones M, et al. Collaborative clinical pharmacokinetic services. Am J Hosp Pharm 1981;38:524-9.
12. Pathak DS, Nold EG. Cost-effectiveness of clinical pharmaceutical services: a follow-up report. Am J Hosp Pharm 1979;36:1527-9.
13. Patterson LE, Huether RJ. Reimbursement for clinical pharmaceutical Services. Am J Hosp Pharm 1978;35:1373-5.
14. Robinson JD. Pharmacokinetics service for ambulatory patients. Am J Hosp Pharm 1981;38:1713-6.
15. Schad R, Schneider PJ, Nold EG. Reimbursable pharmacy teaching program for adrenalectomy patients. Am J Hosp Pharm 1979;36:1212-4.
16. Akaho E, Armstrong EP, Fujii M. Pharmaceutical care innovations in Japan. J Am Pharm Assoc 1996;NS36:123-7.
17. Akaho E, MacLaughlin EJ, Takeuchi Y. Comparison of prescription reimbursement methodologies in Japan and the United States. J Am Pharm Assoc 2003;43:519-26.
18. Armstrong EP, Akaho E, Fujii M. Japanese pharmacy: innovation mixed with tradition. Ann Pharmacother 1995;29:181-5.
19. BCMH announces two new MTMS opportunities. Ohio State Board of Pharmacy News. Feb 2006. Available: www.pharmacy.ohio.gov/sbn2006-02-all.htm (accessed November 13, 2006).
20. Australian Association of Consultant Pharmacy. The facts on accreditation and remuneration for medication reviews. Australia: Australian Association of Consultant Pharmacy; 2006. p. 1-2. Available: www.aacp.com.au (accessed August 20, 2006).
21. Carter BL, Chrischilles EA, Scholz D, et al. Extent of services provided by pharmacists in the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc 2003;43:24-33.
22. Thompson CA. Minnesota pharmacists use CPT codes. Am J Health Syst Pharm 2006;63:1208-10.
23. Centers for Disease Control and Prevention. State-based diabetes prevention & control programs. Available: www.cdc.gov/DIABETES/states (accessed August 11, 2006).
24. Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 2006;40:729-35.
25. Kroger E, Moisan J, Gregoire J. Billing for cognitive services: understanding Quebec pharmacists' behavior. Ann Pharmacother 2000;34:309-16
26. Murphy AL, MacKinnon NJ, Flanagan PS, et al. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees. Ann Pharmacother 2005;39:655-61.
27. Pharmaceutical Services Negotiating Committee. The new contract for community pharmacy: a funding reference guide 2005. Bucks, England: Pharmaceutical Services Negotiating Committee; 2005. Special Edition: 1-24. Available: www.psnc.org.uk/index.php (accessed June 14, 2006).
28. Christensen DB, Holmes G, Fassett WE, et al. Influence of a financial incentive on cognitive services: CARE project design/implementation. J Am Pharm Assoc 1999;39:629-39.
29. Urbis Keys Young. Evaluation of the home medicines review program (Pharmacy Component): final report. Prepared for the Pharmacy Guild of Australia. June 2005. Available: www.guild.org.au/uploadedfiles/Medication_ Management_Reviews/Overview/Urbis%20Keys%20Young% 20evaluation.pdf (accessed October 3, 2007).
30. Smith DH, Fassett WE, Christensen DB. Washington State CARE project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc 1999;39:650-7.
31. National Health Service Scotland. Community pharmacy. Available: www.communitypharmacy.scot.nhs.uk/documentation.html (accessed April 23, 2007).
32. Australian Government. Department of Health and Ageing. Medication management reviews. Available: www. health.gov.au/internet/wcms/publishing.nsf/ Content/Medication+Management+Reviews (accessed November 13, 2006).
33. Australian Government. Medicare Australia. Home Medicines Review. Available: www.medicareaustralia.gov.au/ providers/incentives_allowances/ pharmacy_agreement/hmr.htm (accessed November 13, 2006).
34. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc 2004;44:337-49.
35. Christensen DB, Holmes G, Fassett WE, et al. Principal findings from the Washington State cognitive services demonstration project. Manag Care Interface 1998;11:60-2.
36. The Pharmacy Guild of Australia. About home medicines review. Available: www.beta.guild.org.au/mmr/content. asp?id=53 (accessed August 20, 2006).
37. McDonald S, Lopatka H, Bachynsky J, Kirwin D. Systematic review of pharmacy reimbursement literature. Working Paper. Institute of Health Economics; 1999:99-4:1-63.
38. DaVanzo J, Dobson A, Koenig L, Book R. Medication therapy management services: a critical review. J Am Pharm Assoc 2005;45:580-7.
39. American Academy of Managed Care Pharmacy. Sound medication therapy management programs: 2006 consensus document. Alexandria (VA). Available: www.amcp.org/ amcp.ark?p=AA8CD7EC (accessed October 3, 2007).
40. Poirier S. Reimbursement for cognitive services: Quebec's experience. Am Pharm 1992;NS32:432-60.
41. Poirier S, Gariepy Y. Compensation in Canada for resolving drug-related problems. J Am Pharm Assoc 1996;NS36:117-22.
42. Poirier S, Buffington DE, Memoli GA. Billing third-party payers for pharmaceutical care services. J Am Pharm Assoc 1999;39:50-64.
43. Chang ZG, Kennedy DT, Holdford D, Small RE. Payment for pharmaceutical services. Virginia Pharmacist 2000;84:11-6.
44. Young D. Promising results revealed in Mississippi disease management program. AM J Health Syst Pharm 2003;60: 1720-4.
45. Mississippi Division of Medicaid. Chapter 7. Disease management services. In: Mississippi Division of Medicaid Pharmacy Manual. Mississippi Division of Medicaid; 2006: 7-1-7-56.
46. Anonymous. Medicaid to pay Mississippi pharmacists for disease management. Am J Health Syst Pharm 1998;55:1238-9.
47. Young D. Pharmaceutical case management helps Iowa Medicaid patients. AM J Health Syst Pharm 2003;60:414-6.
48. Bunting BA, Cranor CW. The Asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006;46:133-47.
49. Moore K. Getting paid: billing Medicare for diabetes self-management training. Fam Pract Manag 2002;9(6):18.
50. Reynolds B. Ohio health agency ties MTM services to new CPT codes. American Pharmacists Association. Available: www.pharmacist.com/AM/ PrinterTemplate.cfm?Section=Search1&template=/CM/HTMLDisplay. cfm&ContentID=8638 (accessed January 29, 2008).
51. Vogenberg FR, Hull S. Coding for medication therapy management services. J AHIMA 2006;77:74-9.
52. Benrimoj S, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother 2005;39: 1911-7.
53. Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother 2006;40:512-7.
54. Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the pharmaceutical care project in Minnesota. Am Pharm 1995;NS35:30-9.
55. Minnesota Department of Human Services. MHCP Provider Update PRX-06-02R. Available: www.dhs.state. mn.us/main/groups/business_partners/documents/pub/ dhs_id_055325.hcsp (accessed August 4, 2006).